PLAIO: Funding, Investors & Team (Sep 2026)
PLAIO is a web-based SaaS platform intended to help generic pharmaceutical companies to digitize their demand, manufacturing, and purchase planning.PLAIO offers features like visual and capacity planning, advanced constraint/overhead calculations.
PLAIO has raised $2.3M across 1 funding round on record, the most recent a Seed of $2.3M announced in Dec 2021.
That round is below the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
PLAIO Company Profile and Key Stats
Latest funding round on record: Dec 2021.
PLAIO Funding Rounds
PLAIO Founders and Leadership Team
No contact details are on record for this team yet.
PLAIO Funding Compared to Other Health Care Startups
PLAIO's latest round of $2.3M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PLAIO in Health Care and Reykjavík
Companies Similar to PLAIO
Sidekick is a patient-centric digital care platform that is scalable across a wide range of chronic…
PLAIO is an online software as a service tool designed for generic pharmaceutical companies to streamline…
Kerecis creates licensed fish-skin items to mend the human body. Since no sickness move risk exists between…
EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that…
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
Enhance Fitness is disrupting the Middle East’s personal training industry by enabling individuals to access…
The first scientific wellness platform, Holifya, provides individualised nutritional and preventative…
https://metriport.com
InstaAstro offers individual Astrology consultations, along with Daily Activity Tracks & Content, to assist…
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
PLAIO Funding FAQs
What does PLAIO do?
PLAIO is a web-based SaaS platform intended to help generic pharmaceutical companies to digitize their demand, manufacturing, and purchase planning.PLAIO offers features like visual and capacity planning, advanced constraint/overhead calculations.
How much funding has PLAIO raised?
PLAIO has raised $2.3M across 1 round on record. The most recent is a Seed of $2.3M announced in Dec 2021.
When did PLAIO last raise funding?
PLAIO's most recent funding round on record is a Seed of $2.3M, announced in Dec 2021.
Who is the CEO of PLAIO?
Johann Guobjargarson is listed as CEO at PLAIO.
Where is PLAIO headquartered?
PLAIO is based in Reykjavík, Gullbringusysla, Iceland.
How many employees does PLAIO have?
PLAIO is in the 1-10 employee band.
How does PLAIO's funding compare to other Health Care startups?
PLAIO's latest round of $2.3M is below the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's PLAIO Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PLAIO is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.